Long Lasting Response to Nivolumab and Immune-Related Adverse Events in a NSCLC Patient

Date 05 May 2018
Event ESMO Preceptorship on Immuno-Oncology Lugano May 2018
Session SESSION 6 - Audience Cases
Topics Cancer Immunology and Immunotherapy
Presenter B. Ricciuti, IT